4.6 Article

HOTAIR Modulated Pathways in Early-Stage Breast Cancer Progression

Journal

FRONTIERS IN ONCOLOGY
Volume 11, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2021.783211

Keywords

HOTAIR; lncRNA; breast cancer; DCIS; proliferation; invasion

Categories

Funding

  1. Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-16-1-0027, BC150021]
  2. MD Anderson Cancer Center Support Grant [P30 NIH CA16672]
  3. CPRIT Core Facility [RP170002]
  4. Argentine National Agency of Scientific and Technological Promotion [PICT-2018-01403]
  5. [CA16672]

Ask authors/readers for more resources

The long-non-coding HOX transcript antisense intergenic RNA (HOTAIR) is significantly upregulated in breast ductal carcinoma in situ (DCIS), promoting the progression of early-stage breast cancer by modulating multiple signaling pathways to induce premalignant phenotypic changes.
The long-non-coding HOX transcript antisense intergenic RNA (HOTAIR) was identified as significantly upregulated in breast ductal carcinoma in situ (DCIS). The aim of this study was to characterize the phenotypic effects and signaling pathways modulated by HOTAIR in early-stage breast cancer progression. We determined that HOTAIR induces premalignant phenotypic changes by increasing cell proliferation, migration, invasion and in vivo growth in normal and DCIS breast cell lines. Transcriptomic studies (RNA-seq) identified the main signaling pathways modulated by HOTAIR which include bioprocesses related to epithelial to mesenchymal transition, cell migration, extracellular matrix remodeling and activation of several signaling pathways (HIF1A, AP1 and FGFR). Similar pathways were identified as activated in primary invasive breast carcinomas with HOTAIR over-expression. We conclude that HOTAIR over-expression behaves as a positive regulator of cell growth and migration both in normal and DCIS breast cells involved with early-stage breast cancer progression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available